Venlafaxine for Anxiety in a Patient Who Continues Drinking
Continue venlafaxine (Effexor) for anxiety treatment even if the patient continues drinking, as it can effectively treat both the anxiety disorder and may reduce alcohol-related problems, though you should monitor closely for increased alcohol consumption and adjust dosing based on liver function.
Treatment Approach
Continue Venlafaxine with Modifications
Venlafaxine is FDA-approved for generalized anxiety disorder, social anxiety disorder, and panic disorder 11. The evidence supports continuing this medication even in patients with ongoing alcohol use:
- Dual benefit: Venlafaxine has shown effectiveness in reducing both anxiety symptoms AND alcohol-related problems in patients with comorbid alcohol dependence 23
- In one study, venlafaxine significantly reduced EuropASI scores for alcohol use (from 8.2 to 6.4), psychiatric status (from 7.8 to 5.4), and alcohol craving (from 26.7 to 4.1) over 6 months 2
- Another study showed improvements in depression, alcohol use severity, and family/social functioning in alcohol-dependent patients 3
Dosing Considerations
Standard dosing: 75-225 mg/day of extended-release formulation 11
Critical adjustment needed: If the patient has liver damage from alcohol use, reduce the total daily dose by 50% in patients with mild to moderate hepatic impairment 1. Individual variability may require even greater dose reductions, so monitor liver function tests.
Practical approach:
- Start at 75 mg/day extended-release
- Titrate based on anxiety response and tolerability
- Check liver enzymes before dosing decisions
- If AST/ALT elevated (>2x normal), reduce dose by 50% minimum
Important Caveats
Monitor for Paradoxical Effects
Critical warning: While venlafaxine can help reduce alcohol use in some patients, SSRIs/SNRIs may increase alcohol consumption in patients who are actively drinking 4. Monitor drinking patterns closely, especially in the first 4-8 weeks.
Blood Pressure Monitoring
SNRIs including venlafaxine are associated with sustained hypertension and increased blood pressure 5. Alcohol use can compound cardiovascular risks, so:
- Check blood pressure at each visit
- Consider this especially problematic if patient has hypertension
Overdose Risk
Venlafaxine has been associated with overdose fatalities 5, which is particularly concerning in a patient with substance use issues. Prescribe limited quantities initially and assess suicide risk at each visit.
Adjunctive Medications for Alcohol Use Disorder
Since the patient doesn't want to stop drinking, consider adding:
Evidence-based options for comorbid anxiety-alcohol use:
- Gabapentin or pregabalin: Effective for both anxiety and alcohol use disorder 4
- Buspirone: Shown effective in comorbid anxiety-AUD 4
- Paroxetine (alternative SSRI): Specifically effective in social anxiety with alcohol dependence 4
Avoid benzodiazepines: Despite being mentioned for anxiety in alcohol users 6, they carry high risk for dependence, respiratory depression when combined with alcohol, and complicate the clinical picture.
Discontinuation Planning
If you ever need to stop venlafaxine, taper gradually by reducing 75 mg per week 11. Abrupt discontinuation causes withdrawal symptoms. This is especially important in patients with substance use issues who may be more sensitive to withdrawal states.
Monitoring Schedule
- Weeks 1-4: Weekly visits to assess anxiety response, drinking patterns, blood pressure, and side effects
- Months 2-6: Every 2-4 weeks to monitor for increased alcohol use (paradoxical effect)
- Ongoing: Liver function tests every 3-6 months if drinking continues
- Long-term: Periodically reassess need for continued treatment 1
The key is that venlafaxine remains appropriate and potentially beneficial even with ongoing alcohol use, but requires closer monitoring than in patients without substance use issues 23.